John Bayko writes "Mentioned on Slashdot a couple of years ago, the drug dichloroacetate (DCA) has finally finished its first clinical trial against brain tumors in humans. Drug companies weren't willing to test a drug they could not patent, so money was raised in the community through donations, auctions, and finally government support, but the study was still limited to five patients. It showed extremely positive results in four of them. This episode raises the question of what happens to all the money donated to Canadian and other cancer societies, and especially the billions spent buying merchandise with little pink ribbons on it, if not to actual cancer research like this."

Ant notes a piece up on WBUR Boston addressing theories to explain the universal human experience that time seems to pass faster as you get older. Here's the 9-minute audio (MP3). Several explanations are tried out: that brains lay down more information for novel experiences; that the "clock" for nerve impulses in aging brains runs slower; and that each interval of time represents a diminishing fraction of life as we age.

JamJam writes "The Lancet, a major British medical journal, has retracted a flawed study linking the measles, mumps, and rubella vaccine to autism and bowel disease. British surgeon and medical researcher Andrew Wakefield and his colleagues originally released their study in 1998. Since then 10 of Wakefield's 13 co-authors have renounced the study's conclusions and The Lancet has said it should never have published the research. Wakefield now faces being stripped of his right to practice medicine in Britain. The vaccine-autism debate should now end."

Barence writes "It's desolate, dirty, and sex is outcast to a separate island. In this article, PC Pro's Barry Collins returns to Second Life to find out what went wrong, and why it's raking in more cash than ever before. It's a follow-up to a feature written three years ago, in which Collins spent a week living inside Second Life to see what the huge fuss at the time was all about. The difference three years can make is eye-opening."